Two Sigma Advisers’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,808
Closed -$129K 2611
2024
Q1
$129K Hold
4,808
﹤0.01% 2282
2023
Q4
$65.8K Sell
4,808
-42
-0.9% -$609 ﹤0.01% 2374
2023
Q3
$75.1K Sell
4,850
-1,333
-22% -$25.4K ﹤0.01% 2242
2023
Q2
$134K Sell
6,183
-2,717
-31% -$53.5K ﹤0.01% 2171
2023
Q1
$158K Sell
8,900
-2,958
-25% -$57K ﹤0.01% 2311
2022
Q4
$201K Sell
11,858
-909
-7% -$20.9K ﹤0.01% 2190
2022
Q3
$421K Buy
12,767
+4,134
+48% +$211K ﹤0.01% 1916
2022
Q2
$487K Buy
8,633
+8
+0.1% +$418 ﹤0.01% 1936
2022
Q1
$503K Sell
8,625
-4,617
-35% -$289K ﹤0.01% 1984
2021
Q4
$953K Sell
13,242
-3,341
-20% -$280K ﹤0.01% 1578
2021
Q3
$1.34M Buy
16,583
+8,633
+109% +$757K ﹤0.01% 1476
2021
Q2
$766K Sell
7,950
-1,533
-16% -$157K ﹤0.01% 1757
2021
Q1
$1.14M Buy
9,483
+2,358
+33% +$341K ﹤0.01% 1583
2020
Q4
$932K Sell
7,125
-7,317
-51% -$945K ﹤0.01% 1592
2020
Q3
$1.52M Buy
14,442
+11,884
+465% +$1.46M ﹤0.01% 1302
2020
Q2
$658K Buy
+2,558
New +$974K ﹤0.01% 1769

Other funds holding NXTC

Two Sigma Advisers's NXTC Position: Q2 2024 in Review

Two Sigma Advisers sold out of NextCure (NXTC) in Q2 2024, closing a stake of 4,808 shares — an estimated $129K sold.

Two Sigma Advisers first reported a position in NXTC in Q2 2020 and held it in 16 quarters. The position peaked at $1.52M in Q3 2020. 48 funds tracked by Wall St. Rank hold NXTC as of Q2 2024.

  • Two Sigma Advisers reported no remaining NextCure position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 4,808 NextCure shares in Q2 2024, an estimated $129K.
  • Two Sigma Advisers first reported a position in NextCure in Q2 2020 and held it in 16 quarters.
  • Two Sigma Advisers's NextCure position peaked at $1.52M in Q3 2020.
  • 48 funds tracked by Wall St. Rank held NextCure as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.